Inventor · disambiguated record
Dino Dina
Also filed as: DINA DINO
38 granted patents·10 pending applications·1,346 citations·filing 1987–2022
98Inventor score
Top patents by PatentIndex Score
48 records- 0197US8003115B2Chimeric immunomodulatory compounds and methods of using the sameDYNAVAX TECH CORP·Filed 2007·Granted Aug 23, 2011·41 cites·6 claims
- 0297US7255868B2Chimeric immunomodulatory compounds and methods of using the same—IDYNAVAX TECH CORP·Filed 2002·Granted Aug 14, 2007·83 cites·25 claims
- 0396US7250403B2Biodegradable immunomodulatory formulations and methods for use thereofDYNAVAX TECH CORP·Filed 2001·Granted Jul 31, 2007·71 cites·53 claims
- 0496US7183111B2Immunomodulatory formulations and methods for use thereofDYNAVAX TECH CORP·Filed 2001·Granted Feb 27, 2007·76 cites·41 claims
- 0596US6589940B1Immunostimulatory oligonucleotides, compositions thereof and methods of use thereofDYNAVAX TECH CORP·Filed 1999·Granted Jul 8, 2003·325 cites·50 claims
- 0695US8372413B2Immunomodulatory polynucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2007·Granted Feb 12, 2013·30 cites·22 claims
- 0795US8158768B2Immunostimulatory sequence oligonucleotides and methods of using the sameDINA DINO·Filed 2009·Granted Apr 17, 2012·38 cites·12 claims
- 0895US8124590B2Biodegradable immunomodulatory formulations and methods for use thereofVAN NEST GARY·Filed 2007·Granted Feb 28, 2012·33 cites·23 claims
- 0993US9422564B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2014·Granted Aug 23, 2016·15 cites·17 claims
- 1093US8871732B2Immunostimulatory sequence oligonucleotides and methods of using the sameDINA DINO·Filed 2012·Granted Oct 28, 2014·22 cites·13 claims
- 1193US8597665B2Chimeric immunomodulatory compounds and methods of using the same-IVFEARON KAREN L·Filed 2012·Granted Dec 3, 2013·16 cites·18 claims
- 1293US8222398B2Chimeric immunomodulatory compounds and methods of using the same-IIFEARON KAREN L·Filed 2008·Granted Jul 17, 2012·16 cites·34 claims
- 1393US5156949AImmunoassays for antibody to human immunodeficiency virus using recombinant antigensCHIRON CORP·Filed 1987·Granted Oct 20, 1992·112 cites·22 claims
- 1492US10196643B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2016·Granted Feb 5, 2019·8 cites·17 claims
- 1592US8114418B2Chimeric immunomodulatory compounds and methods of using the same—IVFEARON KAREN L·Filed 2002·Granted Feb 14, 2012·32 cites·15 claims
- 1691US9028845B2Chimeric immunomodulatory compounds and methods of using the same-IVDYNAVAX TECH CORP·Filed 2013·Granted May 12, 2015·10 cites·9 claims
- 1791US8669237B2Biodegradable immunomodulatory formulations and methods for use thereofVAN NEST GARY·Filed 2012·Granted Mar 11, 2014·13 cites·22 claims
- 1890US7785610B2Chimeric immunomodulatory compounds and methods of using the same—IIIDYNAVAX TECH CORP·Filed 2002·Granted Aug 31, 2010·39 cites·7 claims
- 1990US7745606B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2003·Granted Jun 29, 2010·39 cites·10 claims
- 2089US8586555B2Immunomodulatory compositions, formulations, and methods for use thereofFEARON KAREN L·Filed 2009·Granted Nov 19, 2013·12 cites·37 claims
- 2183US5688688AVector for expression of a polypeptide in a mammalian cellCHIRON CORP·Filed 1994·Granted Nov 18, 1997·54 cites·24 claims
- 2280US6096505ANoncloning technique for expressing a gene of interestCHIRON CORP·Filed 1999·Granted Aug 1, 2000·47 cites·36 claims
- 2380US2022267772A1Immunostimulatory sequence oligonucleotides and methods of using the sameTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2478US5206163ADNA encoding bovine diarrhea virus proteinCHIRON CORP·Filed 1990·Granted Apr 27, 1993·59 cites·10 claims
- 2577USRE41158EHuman immunodeficiency virus (HIV) nucleotide sequencesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Granted Mar 2, 2010·1 cites·24 claims
- 2676US11312965B2Immunostimulatory sequence oligonucleotides and methods of using the sameTRISALUS LIFE SCIENCES INC·Filed 2018·Granted Apr 26, 2022·0 cites·13 claims
- 2773US6458527B1HIV immunoassays using gag polypeptidesCHIRON CORP·Filed 1993·Granted Oct 1, 2002·27 cites·33 claims
- 2871US6531276B1Methods for detecting human immunodeficiency virus nucleic acidCHIRON CORP·Filed 1995·Granted Mar 11, 2003·28 cites·45 claims
- 2969US5149529ACompositions and treatment for herpes simplexTRUSTEES OF LELAND CHIRON CORP·Filed 1991·Granted Sep 22, 1992·42 cites·11 claims
- 3061US7393949B1Human immunodeficiency virus (HIV) nucleotide sequencesNOVARTIS VACCINES & DIAGNOSTIC·Filed 1995·Granted Jul 1, 2008·10 cites·24 claims
- 3160US6013432AImmunoassay of HIV antibodies using recombinant or synthetic selected pol sequenceCHIRON CORP·Filed 1995·Granted Jan 11, 2000·17 cites·25 claims
- 3258US2007258994A1Immunomodulatory formulations and methods for use thereofVAN NEST GARY·Filed 2007·Application pending·0 cites
- 3358US2015297737A1Chimeric immunomodulatory compounds and methods of using the same-ivDYNAVAX TECH CORP·Filed 2015·Application pending·0 cites
- 3457US7273695B1HIV immunoassays using synthetic envelope polypeptidesNOVARTIS VACCINES & DIAGNOSTIC·Filed 1993·Granted Sep 25, 2007·10 cites·10 claims
- 3557US2004006034A1Immunostimulatory oligonucleotides, compositions thereof and methods of use thereofFiled 2003·Application pending·0 cites
- 3656US2003064064A1Methods of treating IgE-associated disorders and compositions for use thereinFiled 2002·Application pending·0 cites
- 3755US7285271B1Antigenic composition comprising an HIV gag or env polypeptideNOVARTIS VACCINES & DIAGNOSTIC·Filed 1995·Granted Oct 23, 2007·10 cites·19 claims
- 3849US2007027098A1Immunostimulatory oligonucleotides, compositions thereof and methods of use thereofRAZ EYAL·Filed 2006·Application pending·0 cites
- 3949US2006013811A1Methods of treating IgE-associated disorders and compositions for use thereinDINA DINO·Filed 2005·Application pending·0 cites
- 4049US2003133988A1Immunomodulatory compositions, formulations, and methods for use thereofFiled 2002·Application pending·0 cites
- 4148US2004132677A1Chimeric immunomodulatory compounds and methods of using the same-IVFiled 2003·Application pending·0 cites
- 4247US2003049266A1Immunomodulatory polynucleotides and methods of using the sameFiled 2001·Application pending·0 cites
- 4346US7442525B1Method for expressing HIV polypeptidesNOVARTIS VACCINES & DIAGNOSTIC·Filed 1995·Granted Oct 28, 2008·3 cites·16 claims
- 4439US7205101B1Human immunodeficiency virus (HIV) nucleotide sequences, recombinant polypeptides, and applications thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 1995·Granted Apr 17, 2007·2 cites·19 claims
- 4538US7408053B1Recombinant DNA constructs for GAG polypeptides and polypeptides produced therebyNOVARTIS VACCINES & DIAGNOSTIC·Filed 1995·Granted Aug 5, 2008·1 cites·21 claims
- 4635US7425428B1Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced therebyNOVARTIS VACCINES & DIAGNOSTIC·Filed 1995·Granted Sep 16, 2008·1 cites·14 claims
- 4734US5152982ACompositions and methods for FeLV vaccinationCHIRON CORP·Filed 1991·Granted Oct 6, 1992·3 cites·13 claims
- 4827US7527925B1Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such constructNOVARTIS VACCINES & DIAGNOSTIC·Filed 1995·Granted May 5, 2009·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →